Astena Holdings achieved net sales of \u00a5345.6 billion (+14.8% YoY) in the second quarter of fiscal year 2026, with increases in operating income and net income. Strong performance in the cosmetics and pharmaceutical segments contributed to steady revenue and profit growth.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"8095","jir_company_name":"Astena Holdings Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-07-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/8095-20260713-02.pdf","jir_short_summary":"Astena Holdings achieved net sales of \u00a5345.6 billion (+14.8% YoY) in the second quarter of fiscal year 2026, with increases in operating income and net income. Strong performance in the cosmetics and pharmaceutical segments contributed to steady revenue and profit growth.","jir_summary":"### Performance Overview\nIn the second quarter of fiscal year 2026, Astena Holdings achieved net sales of \u00a5345.6 billion (up 14.8% YoY), showing steady growth driven by expansion in the cosmetics and pharmaceutical businesses. Operating income increased to \u00a5229.0 billion (+3.2%), and net income rose to \u00a5141.7 billion (+10.0%), reflecting overall strong performance. The company is actively promoting new businesses and overseas expansion to strengthen its revenue base.\n\n### Future Outlook and Implications for Investors\nThe company plans to continue expanding sales in cosmetics and pharmaceuticals and aims to grow in overseas markets. Focus will be on acquiring new customers and expanding existing markets, particularly in Asia. These initiatives are expected to support steady full-year performance forecasts, offering investors prospects of stable growth. The company is also proactively investing in capital expenditure and R&D to enhance long-term corporate value.","jir_financial_highlights":"Net Sales: \u00a5345.6 billion (YoY +14.8%)\nOperating Income: \u00a5229.0 billion (YoY +3.2%)\nNet Income: \u00a5141.7 billion (YoY +10.0%)","jir_category":"","jir_hashtags":"#AstenaHoldings, #IRfinancials, #JapanStocks","jir_key_figures":"Net sales: \u00a5345.6 billion (YoY +14.8%)\nOperating income: \u00a5229.0 billion (YoY +3.2%)\nNet income: \u00a5141.7 billion (YoY +10.0%)","jir_meta_title":"\u3010Astena HD\u3011Financial Summary for the Second Quarter of Fiscal Year 2026 | Net Sales \u00a5345.6 billion (+14.8%)","jir_meta_description":"Astena Holdings achieved net sales of \u00a5345.6 billion (+14.8%) in the second quarter of fiscal year 2026. Steady performance supported by expansion in pharmaceutical and cosmetic segments and overseas development.","jir_og_title":"\u3010Astena HD\u3011Financial Summary for the Second Quarter of Fiscal Year 2026 | Net Sales \u00a5345.6 billion","jir_og_description":"Astena Holdings' second quarter of fiscal year 2026 recorded net sales of \u00a5345.6 billion (+14.8%). Growth driven by expansion in pharmaceutical and cosmetic businesses and overseas markets.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"2026 Q1\\\", \\\"2026 Q2\\\"], \\\"datasets\\\": [{\\\"label\\\": \\\"Net Sales\\\", \\\"data\\\": [1700, 3456], \\\"borderColor\\\": \\\"#36A2EB\\\", \\\"fill\\\": false}]}\\\"\"}, {\"jir_chart_id\": \"profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"2026 Q1\\\", \\\"2026 Q2\\\"], \\\"datasets\\\": [{\\\"label\\\": \\\"Operating Income\\\", \\\"data\\\": [2200, 2290], \\\"borderColor\\\": \\\"#4BC0C0\\\", \\\"fill\\\": false}]}\\\"\"}, {\"jir_chart_id\": \"net_profit\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Net Income\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"2026 Q1\\\", \\\"2026 Q2\\\"], \\\"datasets\\\": [{\\\"label\\\": \\\"Net Income\\\", \\\"data\\\": [1300, 1417], \\\"backgroundColor\\\": \\\"#FF6384\\\"}]}\\\"\"}]","ir_related_company":57913,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-79660","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n